Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niall M Corcoran

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Australian Journal of General Practice|November 4, 2025
Beyond age: A holistic approach to predicting 10-year survival of prostate cancer patientsDavid Homewood, Niall M Corcoran
BJU International|September 14, 2013
Modulating the immune response to Bacillus Calmette-Guérin (BCG): a novel way to increase the immunotherapeutic effect of BCG for treatment of bladder cancer?Nikhil Sapre, Niall M Corcoran
Australian Journal of General Practice|April 2, 2020
Advances in prostate cancerFairleigh A Reeves, Niall M Corcoran
Histopathology|January 4, 2012
Targeted therapy in prostate cancerNiall M Corcoran, Martin E Gleave
BJU International|August 18, 2005
Combined low-dose imatinib mesylate and paclitaxel lack synergy in an experimental model of extra-osseous hormone-refractory prostate cancerNiall M Corcoran, Anthony J Costello
Journal of Endourology|April 1, 2011
The impact of laparoscopic nephrectomy on patient outcome: a community perspectiveRichard Grills, Paul Kearns, Niall M Corcoran
Australian Journal of General Practice|May 2, 2024
Guest Editorial: Advances in urologyDavid Homewood, Niall M Corcoran, Damien Bolton
BJU International|April 16, 2011
Lessons learned: end-user assessment of a skills laboratory based training programme for urology traineesRichard Grills, Nathan Lawrentschuk, Niall M Corcoran
The Journal of Urology|January 10, 2004
Inorganic selenium retards progression of experimental hormone refractory prostate cancerNiall M Corcoran, Meri Najdovska, Anthony J Costello
Urology|October 25, 2023
Re: Razdan et al.: The State of Robotic Partial Nephrectomy: Operative, Functional, and Oncological Outcomes From A Robust Multi-Institution Collaborative (Urology 2023;173:92-97)Dinesh K Agarwal, Philip Dundee, Niall M Corcoran
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Australian Journal of General Practice|November 4, 2025
Beyond age: A holistic approach to predicting 10-year survival of prostate cancer patientsDavid Homewood, Niall M Corcoran
BJU International|September 14, 2013
Modulating the immune response to Bacillus Calmette-Guérin (BCG): a novel way to increase the immunotherapeutic effect of BCG for treatment of bladder cancer?Nikhil Sapre, Niall M Corcoran
Australian Journal of General Practice|April 2, 2020
Advances in prostate cancerFairleigh A Reeves, Niall M Corcoran
Histopathology|January 4, 2012
Targeted therapy in prostate cancerNiall M Corcoran, Martin E Gleave
BJU International|August 18, 2005
Combined low-dose imatinib mesylate and paclitaxel lack synergy in an experimental model of extra-osseous hormone-refractory prostate cancerNiall M Corcoran, Anthony J Costello
Journal of Endourology|April 1, 2011
The impact of laparoscopic nephrectomy on patient outcome: a community perspectiveRichard Grills, Paul Kearns, Niall M Corcoran
Australian Journal of General Practice|May 2, 2024
Guest Editorial: Advances in urologyDavid Homewood, Niall M Corcoran, Damien Bolton
BJU International|April 16, 2011
Lessons learned: end-user assessment of a skills laboratory based training programme for urology traineesRichard Grills, Nathan Lawrentschuk, Niall M Corcoran
The Journal of Urology|January 10, 2004
Inorganic selenium retards progression of experimental hormone refractory prostate cancerNiall M Corcoran, Meri Najdovska, Anthony J Costello
Urology|October 25, 2023
Re: Razdan et al.: The State of Robotic Partial Nephrectomy: Operative, Functional, and Oncological Outcomes From A Robust Multi-Institution Collaborative (Urology 2023;173:92-97)Dinesh K Agarwal, Philip Dundee, Niall M Corcoran
Pageof 17